Peter Weinstein, PhD - Chief Executive Officer
Provides over two decades of legal and business experience working and building small companies in the biotech/pharma/hi tech space around the world; built Genomics Enterprises, the commercial arm of Genomics England that included 12 companies, including many of the largest pharma
Michael Reilly, MBA - Chief Operating Officer
Brings thirty years of international leadership experience in marketing, business development, strategy, and finance at Amgen, Baxter, Sanofi, Sterling Drug, and Eastman Kodak. Michael was the commercial lead for Amgen's acquisition of Immunex and its drug Enbrel and he led the denosumab (PROLIA, XGEVA) team.